Autoimmune diseases are a group of debilitating illnesses that are often idiopathic in nature. The steady rise in the prevalence of these conditions warrants new approaches for diagnosis and treatment. Stimuli‐responsive biomaterials also known as “smart,” “intelligent,” or “recognitive” biomaterials are widely studied for their applications in drug delivery, biosensing, and tissue engineering due to their ability to produce thermal, optical, chemical, or structural changes upon interacting with the biological environment. Studies within the last decade that harness the recognitive capabilities of these biomaterials toward the development of novel detection and treatment options for autoimmune diseases are critically analyzed.